The Impact of Carotid Endarterectomy on Choriocapillaris Perfusion.

"Disclosure: S.W. Zhou, None; Y. Zhang, None; N. Noam, None; D. Rabinovitch, None; D. Bar, None; B.S. Yousif, None; R. O'Brien, None; F.E. Hiya, None; Y. Lin, None; A. Berni, None; G. Gregori, Carl Zeiss Meditec (F); R.K. Wang, Carl Zeiss Meditec (C, F), Colgate Palmolive (F), Cyberdontics (C), Estee Lauder (F); P.J. Rosenfeld, Bayer Pharmaceuticals (C), Annexon (C), Apellis (C, F), Boehringer-Ingelheim (C), Carl Zeiss Meditec (C, F), Genentech/Roche (C), Gyroscope Therapeutics (F), InflammX Therapeutics (C, F), Ocudyne (C, F), Regeneron Pharmaceuticals (C), Unity Biotechnology (C), Valitor (F); O. Trivizki, None"

"Supported in part by an unrestricted grant from Research to Prevent Blindness, by Carl Zeiss Meditec, and by grants from the National Institutes of Health (P30EY014801, R01EY028753, and R01AG060942). The funding organizations had no role in the design or conduct of the present research."